Advances in Pharmacodynamics and Drug Design Process
A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Pharmaceutical Processes".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 2216
Special Issue Editors
Interests: experimental pharmacology; clinical pharmacology; dermatology; antiaging medicine; pharmacodynamics of plant extracts
Interests: anti-bacterial agents; pharmacokinetics; stress hormones; clinical studies
Special Issues, Collections and Topics in MDPI journals
Interests: experimental pharmacology; clinical pharmacology; neuropsychopharmacology
Interests: diabetes; nutrition; metabolic diseases
Special Issues, Collections and Topics in MDPI journals
Interests: experimental pharmacology; clinical pharmacology; gastroenterology; pain medicine; antiaging medicine
Special Issue Information
Dear Colleagues,
Experimental pharmacology is a vast field based on research for drug design that is used for the discovery and evaluation of new active substances, and it is indispensable in the non-clinical development of medicines. In a broader sense, experimental pharmacology is an essential tool in the advancement of preclinical and clinical studies used in the process of drug design and the evaluation, and authorization of new substances. For this purpose, pharmacokinetics, pharmacodynamics, and pharmacotoxicology research is carried out. Sometimes, in the process of developing new drugs in clinical trials, research can return to the experimental, non-clinical phase, precisely to find new mechanisms of action of the substances undergoing testing, which results from clinical observations. There are many situations in which pharmacology, for example discovering new pharmacological receptors, opens horizons for the description of new molecular structures or previously unknown biological functions, which are then explored by physiologists, biologists, or pathologists.
This Special Issue entitled “Advances in Pharmacodynamics and Drug Design Process” intends to present both reviews and original studies regarding research on the drug design process and also the mechanism of action of different substances by using experimental pharmacology methods.
The topics in this Special Issue include but are not limited to:
- Experimental pharmacology in drug design
- Clinical pharmacology in drug design
- Neuropsychopharmacology
- Pharmacology of pain
- Pharmacology in metabolic diseases
Prof. Dr. Oana Andreia Coman
Prof. Dr. Cristina Mihaela Ghiciuc
Dr. Isabel Ghiță
Dr. Anca Pantea Stoian
Dr. Horia Păunescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- experimental pharmacology
- clinical pharmacology
- pain
- metabolic diseases
- central nervous system diseases
- drug design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
